4.7 Article

Elevated microsomal prostaglandin-E synthase-1 in Alzheimer's disease

期刊

ALZHEIMERS & DEMENTIA
卷 4, 期 1, 页码 6-13

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jalz.2007.10.015

关键词

beta-amyloid; cyclooxygenase; middle frontal gyrus; neuroinflammation; PGES

资金

  1. NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046400] Funding Source: NIH RePORTER
  2. NATIONAL INSTITUTE ON AGING [P50AG005146, R01AG022971] Funding Source: NIH RePORTER
  3. NIA NIH HHS [R01 AG022971, R01 AG022971-02, P50 AG005146, AG05146, AG022971] Funding Source: Medline
  4. NINDS NIH HHS [R01 NS046400-02, NS046400, R01 NS046400] Funding Source: Medline

向作者/读者索取更多资源

Background: The proinflammatory prostaglandin E, (PGE(2)) fluctuates over time in the cerebrospinal fluid of patients with Alzheimer's disease (AD), but the cerebral distribution and expression patterns of microsomal prostaglandin-E synthase (mPGES)-1 have not been compared with those of normal human brains. Methods: Middle frontal gyrus tissue from AD and age-matched control brains was analyzed by Western blot, immunofluorescence, and immunohistochemistry with mPGES-1-specific antibodies. Results: Western blotting revealed that mPGES-1 expression was significantly elevated in AD tissue. Furthermore, immunofluorescence of mPGES-1 was observed in neurons, microglia, and endothelial cells of control and AD tissue. Although mPGES-1 was consistently present in astrocytes of control tissue, it was present in only some astrocytes of AD tissue. Immunohistochemical staining suggested that mPGES-1 was elevated in pyramidal neurons of AD tissue when compared with controls. Conclusions: The results suggest that mPGES-1 is normally expressed constitutively in human neurons, microglia, astrocytes, and endothelial cells but is up-regulated in AD. (C) 2008 The Alzheimer's Association. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Anesthesiology

Role of Dexmedetomidine in Aneurysmal Subarachnoid Hemorrhage: A Comprehensive Scoping Review

Hongtao Liu, Katharina M. Busl, Sylvain Dore

Summary: Dexmedetomidine (DEX), an alpha(2)-adrenergic agonist, has various beneficial effects such as anti-inflammation, antioxidation, and anticell death. It has shown potential as a protective therapy for patients with subarachnoid hemorrhage (SAH) by maintaining stable intracerebral homeostasis, repairing blood-brain barrier damage, and preventing vasospasm and cortical spreading depolarization. However, more clinical trials and translational research are needed to further evaluate its effectiveness.

JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY (2022)

Article Clinical Neurology

Haptoglobin Genotype Affects Inflammation after Aneurysmal Subarachnoid Hemorrhage

Aaron M. Gusdon, Jude Savarraj, Liang Zhu, Peeyush K. Thankamani Pandit, Sylvain Dore, Devin W. McBride, HuiMahn A. Choi, Spiros L. Blackburn

Summary: This study revealed that patients with the HP 2-2 genotype showed higher levels of inflammatory cytokines at all time points compared to those with HP 1-1/1-2 genotypes. However, there were no significant differences in functional outcomes between the two groups. These findings may guide future research in identifying markers for functional prognosis or treatment targets.

CURRENT NEUROVASCULAR RESEARCH (2021)

Review Biochemistry & Molecular Biology

Soluble Receptors Affecting Stroke Outcomes: Potential Biomarkers and Therapeutic Tools

Ayon Bhattacharya, Rani Ashouri, Madison Fangman, Alexandra Mazur, Timothy Garett, Sylvain Dore

Summary: Soluble receptors, formed through cleavage from membrane-bound counterparts, play key roles in inflammation, oxidative stress, and stroke management. Their unique structures enable them to modulate receptor signaling and exhibit dual functions in cell protection.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cell & Tissue Engineering

Spiny mouse (Acomys): an emerging research organism for regenerative medicine with applications beyond the skin

Janak Gaire, Justin A. Varholick, Sabhya Rana, Michael D. Sunshine, Sylvain Dore, W. Brad Barbazuk, David D. Fuller, Malcolm Maden, Chelsey S. Simmons

Summary: The spiny mouse is an exciting research organism due to its remarkable scarless healing abilities in various tissues beyond the skin, which could shed light on numerous clinically relevant human diseases. However, there are challenges in working with this emerging research organism that require future strategies and methods.

NPJ REGENERATIVE MEDICINE (2021)

Review Clinical Neurology

Nutritional Supplementation of Naturally Occurring Vitamin D to Improve Hemorrhagic Stroke Outcomes

Rani Ashouri, Madison Fangman, Jordan Brielmaier, Zoe A. Fields, Natalie Campo, Sylvain Dore

Summary: Vitamin D deficiency is associated with bone disorders, cardiovascular damage, and an increased risk of ischemic stroke if left untreated. Research suggests that dietary vitamin D may impact the pathology of hemorrhagic stroke through potential mechanisms.

FRONTIERS IN NEUROLOGY (2021)

Article Biochemistry & Molecular Biology

Association of Serum Bilirubin with the Severity and Outcomes of Intracerebral Hemorrhages

Kai Fu, Cynthia S. Garvan, Shelley C. Heaton, Nandakumar Nagaraja, Sylvain Dore

Summary: This study found that higher levels of direct bilirubin were associated with greater stroke severity at presentation and worse outcomes at discharge among patients with ICH. On the other hand, higher levels of albumin were associated with lower stroke severity and better clinical outcomes. Future prospective studies on the free bioactive bilirubin are needed to better understand the intricate relationships between bilirubin and ICH.

ANTIOXIDANTS (2021)

Review Biochemistry & Molecular Biology

Role of CRF and the hypothalamic-pituitary-adrenal axis in stroke: revisiting temporal considerations and targeting a new generation of therapeutics

Daniel A. Lichlyter, Zachary A. Krumm, Todd A. Golde, Sylvain Dore

Summary: Ischaemic neurovascular stroke is a major cause of death in developed countries, and the corticotropin-releasing factor (CRF) family of neuropeptides plays an important role in the pathology of acute neurovascular injury. However, there is still limited understanding of the pathway, temporality, and systemic impact of CRF signaling and stress biology in the progression of neurovascular injury. This review aims to investigate the potential benefits of a CRF antibody in modulating CRF and corticotropin-releasing factor receptor 1 signaling, glucocorticoids, and autonomic nervous system activity, and compare the modulation of CRF and HPA axis activity in neuropsychiatric diseases and post-stroke outcomes with lessons learned from antibody therapies in neurodegenerative diseases.

FEBS JOURNAL (2023)

Article Clinical Neurology

Genome-Wide Association Study of Clinical Outcome After Aneurysmal Subarachnoid Haemorrhage: Protocol

Ben Gaastra, Sheila Alexander, Mark K. Bakker, Hemant Bhagat, Philippe Bijlenga, Spiros Blackburn, Malie K. Collins, Sylvain Dore, Christoph Griessenauer, Philipp Hendrix, Eun Pyo Hong, Isabel C. Hostettler, Henry Houlden, Koji IIhara, Jin Pyeong Jeon, Bong Jun Kim, Munish Kumar, Sandrine Morel, Paul Nyquist, Dianxu Ren, Ynte M. Ruigrok, David Werring, Ian Galea, Diederik Bulters, Will Tapper

Summary: This article introduces a two-stage genome-wide association study on susceptibility loci for clinical outcome after aneurysmal subarachnoid hemorrhage (aSAH). Only a small fraction of the variation in clinical outcome can be explained by known clinical, demographic, and imaging variables, suggesting the involvement of unknown factors. Understanding the genetic determinants of outcome is crucial for improving prognostic modeling, stratifying patients in clinical trials, and developing novel treatment strategies.

TRANSLATIONAL STROKE RESEARCH (2022)

Article Genetics & Heredity

Influence of Haptoglobin Polymorphism on Stroke in Sickle Cell Disease Patients

Olivia Edwards, Alicia Burris, Josh Lua, Diana J. Wilkie, Miriam O. Ezenwa, Sylvain Dore

Summary: This review examines the role of haptoglobin genetic polymorphism and stroke occurrence in the pathophysiology of sickle cell disease. It suggests that further research should be conducted to explore potential clinical advancements in gene therapy and Hp infusions.
Review Clinical Neurology

Contribution of Various Types of Transfusion to Acute and Delayed Intracerebral Hemorrhage Injury

Siddharth Kumar, Matthew Andoniadis, Ali Solhpour, Salman Asghar, Madison Fangman, Rani Ashouri, Sylvain Dore

Summary: This study reviews transfusion therapies with platelets, fresh frozen plasma, prothrombin complex concentrate, and red blood cells in patients with intracerebral hemorrhage, aiming to limit hematoma expansion and reduce brain edema development.

FRONTIERS IN NEUROLOGY (2021)

Review Neurosciences

Effects of Sound Interventions on the Permeability of the Blood-Brain Barrier and Meningeal Lymphatic Clearance

Sean Sachdeva, Sushmita Persaud, Milani Patel, Peyton Popard, Aaron Colverson, Sylvain Dore

Summary: This review discusses the effects of music/sound on blood-brain barrier permeability and meningeal lymphatic clearance, highlighting its potential positive impact on brain and body functions. However, there is limited knowledge regarding the systematic investigation and outcomes of using music/sound in medical interventions. Further research is needed to explore the potential of music/sound in healthcare.

BRAIN SCIENCES (2022)

Article Clinical Neurology

A Genome-Wide Association Study of Outcome After Aneurysmal Subarachnoid Haemorrhage: Discovery Analysis

Ben Gaastra, Sheila Alexander, Mark K. Bakker, Hemant Bhagat, Philippe Bijlenga, Spiros L. Blackburn, Malie K. Collins, Sylvain Dore, Christoph J. Griessenauer, Philipp Hendrix, Eun Pyo Hong, Isabel C. Hostettler, Henry Houlden, Koji IIhara, Jin Pyeong Jeon, Bong Jun Kim, Jiang Li, Sandrine Morel, Paul Nyquist, Dianxu Ren, Ynte M. Ruigrok, David Werring, Will Tapper, Ian Galea, Diederik Bulters

Summary: This study identified 157 genetic variants associated with outcomes after aneurysmal subarachnoid haemorrhage (aSAH) through a genome-wide association study, with one variant in the SPNS2 gene achieving genome-wide significance. Validation of these findings will provide significant insights into the pathophysiology of outcomes after aSAH and may have implications for treatment.

TRANSLATIONAL STROKE RESEARCH (2023)

Article Neurosciences

Evidence-based interconversion of the Glasgow Outcome and modified Rankin scales: pitfalls and best practices

Ben Gaastra, Dianxu Ren, Sheila Alexander, Issam A. Awad, Spiros Blackburn, Sylvain Dore, Dan Hanley, Paul Nyquist, Diederik Bulters, Ian Galea

Summary: This study demonstrates the high correlation between the modified Rankine Scale (mRS) and Glasgow Outcome Scale (GOS) and establishes the optimal dichotomization threshold for agreement. The study also provides a method for interconversion and finds that conversion from mRS to GOS is better than the reverse direction.

JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2022)

Review Clinical Neurology

Obstructive Sleep Apnea and Stroke: Determining the Mechanisms Behind their Association and Treatment Options

Basma Mohamed, Keerthi Yarlagadda, Zachary Self, Alexandra Simon, Frank Rigueiro, Maryam Sohooli, Stephan Eisenschenk, Sylvain Dore

Summary: Sleep-disordered breathing, including obstructive sleep apnea, is a common sequela and risk factor for stroke. This scoping review investigates the relationship between obstructive sleep apnea and stroke outcomes, highlighting the pathophysiology and the importance of treatment. Understanding this relationship has implications for the clinical management and prognosis of patients with acute ischemic stroke.

TRANSLATIONAL STROKE RESEARCH (2023)

Meeting Abstract Endocrinology & Metabolism

Brain hemorrhage: Beyond the neuron

Marietta Zille, Jaroslaw Aronowski, Nicole A. Terpolilli, Sylvain Dore

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2022)

暂无数据